Consequently, female breast cancer is primarily categorized into four subtypes based on receptor types, i.e., HR+/HER2-, HR-/HER2-, HR+/HER2+, HR-/HER2+ (Lopez-Tarruella et al., 2022). This evidence concerns the gene ERBB2 and breast cancer.